Trial intelligence / Profile preview

Lovastatin for treating manic symptoms of bipolar disorder

IRCT201302203930N18Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of lovastatin in bipolar disorder (BD), sponsored by Shiraz University of Medical Sciences. Started Nov 2011; status: completed.

02

Drugs

lovastatin
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on IRCT201302203930N18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201302203930N18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call